Candidates throughout the campaigns promised to provide a platform for the people of Kisoro so that their issues are heard ...

DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

Other MS patients, a minority, have a form of the disease that features gradually increasing progressive disability from onset—so-called primary progressive MS (PPMS). While effective disease ...

"I'm just, I'm frustrated," said Rhonda Mirabella.Rhonda Mirabella is masking her emotions. She's hurt and angry with the ...

After a series of tests and a lumbar puncture, Mr Foniadakis was told he had “one of the worst kinds” of multiple sclerosis — ...

with the HERCULES trial meeting its primary endpoint while the GEMINI trials did not. The HERCULES study focused on the efficacy and safety of tolebrutinib in individuals with non-relapsing secondary ...

Kamala Harris lost because the country is moving away from what her party stands for today. And as the race for 2028 begins, ...

President-elect Donald J. Trump has burst onto the transition scene with energy and important pronouncements, including ...

A fourth phase 3 trial called PERSEUS in patients with primary progressive MS (PPMS) is still ongoing, with results due next year. There is a much greater need for new therapies for progressive ...

Secondary imaging endpoints generally were in the same direction as the primary endpoint. Plasma levels of NfL ... in people ...

Roche is running three late-stage studies, namely FENhance 1 and 2 trials in relapsing MS, comparing the drug to Sanofi's Aubagio (teriflunomide) and the FENtrepid trial in primary progressive MS ...

Patients with severe forms of MS had encouraging results with a autologous hematopoietic stem cell transplantation in a large-scale real-world cohort.